JP2018511648A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018511648A5 JP2018511648A5 JP2017555866A JP2017555866A JP2018511648A5 JP 2018511648 A5 JP2018511648 A5 JP 2018511648A5 JP 2017555866 A JP2017555866 A JP 2017555866A JP 2017555866 A JP2017555866 A JP 2017555866A JP 2018511648 A5 JP2018511648 A5 JP 2018511648A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound
- alkyl
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 31
- 150000003839 salts Chemical class 0.000 claims description 18
- 102100021977 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Human genes 0.000 claims description 10
- 108050004000 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Proteins 0.000 claims description 10
- 238000012879 PET imaging Methods 0.000 claims description 8
- 238000003384 imaging method Methods 0.000 claims description 6
- 238000001727 in vivo Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000002603 single-photon emission computed tomography Methods 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 239000003446 ligand Substances 0.000 claims description 4
- 125000004429 atom Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000011260 co-administration Methods 0.000 claims description 2
- 125000002971 oxazolyl group Chemical group 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 230000002285 radioactive effect Effects 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562105336P | 2015-01-20 | 2015-01-20 | |
| US62/105,336 | 2015-01-20 | ||
| PCT/IB2016/050276 WO2016116875A1 (en) | 2015-01-20 | 2016-01-20 | Pet imaging agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020106739A Division JP2020158532A (ja) | 2015-01-20 | 2020-06-22 | Ｐｅｔイメージング剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018511648A JP2018511648A (ja) | 2018-04-26 |
| JP2018511648A5 true JP2018511648A5 (enExample) | 2019-02-21 |
| JP6723264B2 JP6723264B2 (ja) | 2020-07-15 |
Family
ID=55300733
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555866A Expired - Fee Related JP6723264B2 (ja) | 2015-01-20 | 2016-01-20 | Ｐｅｔイメージング剤 |
| JP2020106739A Pending JP2020158532A (ja) | 2015-01-20 | 2020-06-22 | Ｐｅｔイメージング剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020106739A Pending JP2020158532A (ja) | 2015-01-20 | 2020-06-22 | Ｐｅｔイメージング剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10450298B2 (enExample) |
| EP (1) | EP3247706B1 (enExample) |
| JP (2) | JP6723264B2 (enExample) |
| KR (1) | KR20170103960A (enExample) |
| CN (1) | CN107406419B (enExample) |
| AU (1) | AU2016209906A1 (enExample) |
| BR (1) | BR112017015455A2 (enExample) |
| CA (1) | CA2974311A1 (enExample) |
| EA (1) | EA201791643A1 (enExample) |
| ES (1) | ES2828715T3 (enExample) |
| MX (1) | MX2017009452A (enExample) |
| WO (1) | WO2016116875A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2974311A1 (en) | 2015-01-20 | 2016-07-28 | Novartis Ag | Pet imaging agents |
| TWI809597B (zh) * | 2020-12-16 | 2023-07-21 | 美商美國禮來大藥廠 | 預靶向造影劑 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0224917D0 (en) * | 2002-10-25 | 2002-12-04 | Novartis Ag | Organic compounds |
| WO2005043300A2 (en) | 2003-10-20 | 2005-05-12 | Empirix, Inc. | Computer language interpretation and optimization for server testing |
| BRPI0510512A (pt) | 2004-04-28 | 2007-10-30 | Icos Corp | derivados de arilfenilamino, arilfenilamida e sulfeto de arilfeniléter |
| WO2005121094A1 (en) | 2004-06-09 | 2005-12-22 | Pfizer Limited | Piperazine and piperidine derivatives as anti-hiv-agents |
| CN101429161A (zh) * | 2008-12-05 | 2009-05-13 | 常熟理工学院 | Pet显像剂前体异喹啉甲酰胺衍生物的合成方法 |
| JP5767205B2 (ja) * | 2009-04-02 | 2015-08-19 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | オートタキシン阻害剤としての複素環式化合物 |
| US8999974B2 (en) | 2010-08-09 | 2015-04-07 | Raqualia Pharma Inc. | Acyl piperazine derivatives as TTX-S blockers |
| JP2013536200A (ja) * | 2010-08-20 | 2013-09-19 | アミラ ファーマシューティカルス，インコーポレーテッド | オートタキシン阻害剤およびその使用 |
| PT2861566T (pt) * | 2012-06-13 | 2017-02-08 | Hoffmann La Roche | Novos diazaspirocicloalcanos e azaspirocicloalcanos |
| CN104968656B (zh) * | 2012-12-19 | 2017-08-11 | 诺华股份有限公司 | 自分泌运动因子抑制剂 |
| SG11201600241RA (en) | 2013-07-18 | 2016-02-26 | Novartis Ag | Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core |
| CA2974311A1 (en) | 2015-01-20 | 2016-07-28 | Novartis Ag | Pet imaging agents |
-
2016
- 2016-01-20 CA CA2974311A patent/CA2974311A1/en not_active Withdrawn
- 2016-01-20 EP EP16702985.9A patent/EP3247706B1/en active Active
- 2016-01-20 MX MX2017009452A patent/MX2017009452A/es unknown
- 2016-01-20 CN CN201680016753.9A patent/CN107406419B/zh active Active
- 2016-01-20 ES ES16702985T patent/ES2828715T3/es active Active
- 2016-01-20 KR KR1020177022757A patent/KR20170103960A/ko not_active Withdrawn
- 2016-01-20 JP JP2017555866A patent/JP6723264B2/ja not_active Expired - Fee Related
- 2016-01-20 US US15/544,850 patent/US10450298B2/en active Active
- 2016-01-20 EA EA201791643A patent/EA201791643A1/ru unknown
- 2016-01-20 BR BR112017015455-2A patent/BR112017015455A2/pt not_active Application Discontinuation
- 2016-01-20 WO PCT/IB2016/050276 patent/WO2016116875A1/en not_active Ceased
- 2016-01-20 AU AU2016209906A patent/AU2016209906A1/en not_active Abandoned
-
2019
- 2019-09-24 US US16/581,086 patent/US10865195B2/en active Active
-
2020
- 2020-06-22 JP JP2020106739A patent/JP2020158532A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2324686C2 (ru) | ПРОИЗВОДНЫЕ ТИОФЛАВИНА, СВЯЗЫВАЮЩИЕ АМИЛОИД, СПОСОБ ОБНАРУЖЕНИЯ in vivo ОТЛОЖЕНИЙ АМИЛОИДА И СПОСОБ РАСПОЗНАВАНИЯ БОЛЕЗНИ АЛЬЦГЕЙМЕРА | |
| US8435489B2 (en) | Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma | |
| JP2017501236A5 (enExample) | ||
| JP2010526089A5 (enExample) | ||
| JP2010523599A5 (enExample) | ||
| JP2015525782A5 (enExample) | ||
| JP2015504067A5 (enExample) | ||
| Chefer et al. | In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I] iodo-A-85380 using single photon emission computed tomography | |
| JP2010524857A5 (enExample) | ||
| Sanad et al. | Radiochemical and biological evaluation of 99mTc-Labeling of phthalic acid using 99mTc-Tricabonyl and 99mTc-Sn (II) as a model for potential hazards imaging | |
| RU2005131872A (ru) | Производные бензотиазола (варианты), фармацевтическая композиция для детекции отложений амилоида и способ их детекции у млекопитающего | |
| JP2018511648A5 (enExample) | ||
| JP2007500730A5 (enExample) | ||
| JP2019527225A (ja) | Ｉｄｏ１酵素イメージングのための放射性リガンド | |
| JP2018520124A5 (enExample) | ||
| JP2009538894A5 (enExample) | ||
| JP2012504581A5 (enExample) | ||
| CN102557969A (zh) | 环酮类衍生物及其作为淀粉样蛋白沉积物和神经纤维缠结的显像剂和聚集抑制剂的用途 | |
| US20100228012A1 (en) | Pendant fatty acid imaging agents | |
| JP2013507345A5 (enExample) | ||
| US20230095707A1 (en) | Multimodal fluorine-cy3/5/7-dota-hapten compositions, diagnostics, fluorescence guided surgery and radioimmunotherapy | |
| JP2012523388A5 (enExample) | ||
| KR101920902B1 (ko) | 심혈관 질환 조기진단 pet 조영용 화합물 및 그의 용도 | |
| JP2017206457A (ja) | 肝臓及び／又は腎臓機能の診断剤 | |
| Gao et al. | Pharmacokinetics and biodistribution of 99mTc N-MPO in healthy human volunteers |